102 related articles for article (PubMed ID: 4039593)
21. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia.
Kurowska EM; Jordan J; Spence JD; Wetmore S; Piché LA; Radzikowski M; Dandona P; Carroll KK
Clin Invest Med; 1997 Jun; 20(3):162-70. PubMed ID: 9189647
[TBL] [Abstract][Full Text] [Related]
22. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
Simons LA; Hickie JB; Balasubramaniam S
Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
[TBL] [Abstract][Full Text] [Related]
23. Alterations in plasma lipid levels resulting from tofu and cheese consumption in adult women.
Meredith L; Liebman M; Graves K
J Am Coll Nutr; 1989 Dec; 8(6):573-9. PubMed ID: 2621294
[TBL] [Abstract][Full Text] [Related]
24. Influence of diets containing cow's milk or soy protein beverage on plasma lipids in children with familial hypercholesterolemia.
Jacques H; Laurin D; Moorjani S; Steinke FH; Gagné C; Brun D; Lupien PJ
J Am Coll Nutr; 1992 Jun; 11 Suppl():69S-73S. PubMed ID: 1619204
[TBL] [Abstract][Full Text] [Related]
25. Changes in plasma lipids and lipoproteins after a modified fat diet.
Ernst N; Fisher M; Bowen P; Schaefer EJ; Levy RI
Lancet; 1980 Jul; 2(8186):111-3. PubMed ID: 6105293
[TBL] [Abstract][Full Text] [Related]
26. High protein diet complements resin therapy of familial hypercholesterolemia.
Wolfe BM; Giovannetti PM
Clin Invest Med; 1992 Aug; 15(4):349-59. PubMed ID: 1516292
[TBL] [Abstract][Full Text] [Related]
27. Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet.
Weghuber D; Widhalm K
Br J Nutr; 2008 Feb; 99(2):281-6. PubMed ID: 17697400
[TBL] [Abstract][Full Text] [Related]
28. Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.
Negele L; Schneider B; Ristl R; Stulnig TM; Willfort-Ehringer A; Helk O; Widhalm K
Eur J Clin Nutr; 2015 Mar; 69(3):337-43. PubMed ID: 25424602
[TBL] [Abstract][Full Text] [Related]
29. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
Hoeg JM; Maher MB; Zech LA; Bailey KR; Gregg RE; Lackner KJ; Fojo SS; Anchors MA; Bojanovski M; Sprecher DL
Am J Cardiol; 1986 Apr; 57(11):933-9. PubMed ID: 3515897
[TBL] [Abstract][Full Text] [Related]
31. Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.
Kłosiewicz-Latoszek L; Nowicka G; Szostak WB; Naruszewicz M
Atherosclerosis; 1987 Feb; 63(2-3):203-9. PubMed ID: 3827981
[TBL] [Abstract][Full Text] [Related]
32. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
Yamamoto K; Fukushima N; Ozaki I; Setoguchi Y; Yanagita T; Sakai T
Artery; 1991; 18(3):133-49. PubMed ID: 2069518
[TBL] [Abstract][Full Text] [Related]
33. The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia.
Hoeg JM; Maher MB; Bailey KR; Brewer HB
Atherosclerosis; 1986 Jun; 60(3):209-14. PubMed ID: 3524586
[TBL] [Abstract][Full Text] [Related]
34. [The effect of low and high molecular weight dextrans on selected lipid parameters in serum. Part 3].
Rühlmann C; Koksch M; Hohdorf K; Kuklinski B
Z Gesamte Inn Med; 1993 Aug; 48(8):381-5. PubMed ID: 7691019
[TBL] [Abstract][Full Text] [Related]
35. Influence of dietary fat on plasma lipid profiles of Malaysian adolescents.
Marzuki A; Arshad F; Razak TA; Jaarin K
Am J Clin Nutr; 1991 Apr; 53(4 Suppl):1010S-1014S. PubMed ID: 1901440
[TBL] [Abstract][Full Text] [Related]
36. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia].
Sziegoleit W; Wichmann T; Block HU; Taube C; Mest HJ
Wien Klin Wochenschr; 1991; 103(8):227-31. PubMed ID: 1858388
[TBL] [Abstract][Full Text] [Related]
37. Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolemia.
Widhalm K; Brazda G; Schneider B; Kohl S
J Pediatr; 1993 Jul; 123(1):30-4. PubMed ID: 8320622
[TBL] [Abstract][Full Text] [Related]
38. Effect of polyunsaturated isocaloric fat diets on plasma lipids, apolipoproteins and fatty acids.
Blaton V; De Buyzere M; Declercq B; Pracetyo A; Vanderkelen G; Delanghe J; Spincemaille J
Atherosclerosis; 1984 Oct; 53(1):9-20. PubMed ID: 6497946
[TBL] [Abstract][Full Text] [Related]
39. Continued benefit of lovastatin in the treatment of hypercholesterolemia in 36 patients.
Wallace MB; Warren SG; Bates MC; Robinson PA
W V Med J; 1995 Feb; 91(2):50-3. PubMed ID: 7610642
[TBL] [Abstract][Full Text] [Related]
40. [Dietary treatment of patients with familial hyperlipoproteinemias].
Solovév EIu; Rozhkova TA; Koshechkin VA; Pogozhaeva AV
Kardiologiia; 1992; 32(11-12):56-8. PubMed ID: 1297883
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
